Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2016

Sep 17, 2016

34129_dirs_2016-09-16_b6c161e3-1d1a-4204-8fc7-bfd89df87996.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-09-14

Reporting Person: Spitznagel Thomas (Sr VP, BPD & Manufacturing)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-14 Employee Stock Option (right to buy) $28.94 A 20000 Acquired 2026-09-14 Common Stock (20000) Direct

Footnotes

F1: 12.5% of the option becomes exercisable on March 14, 2017 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.